We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current STTK market cap is 347.75M. The company's latest EPS is USD -1.8388 and P/E is -4.02.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 390k | 57k | 200k | 686k | 714k |
Operating Income | -26.28M | -21.66M | -22.75M | -28.6M | -18.95M |
Net Income | -25.41M | -20.72M | -21.35M | -27.54M | -17.69M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 9.89M | 9.93M | 30.02M | 652k | 1.66M |
Operating Income | -25.07M | -36.93M | -45.27M | -103.33M | -91.96M |
Net Income | -23.98M | -36.6M | -44.97M | -101.95M | -87.3M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 205.32M | 177.68M | 155.27M | 130.46M | 159.56M |
Total Liabilities | 29.17M | 20.02M | 16.81M | 17.67M | 14.86M |
Total Equity | 176.16M | 157.65M | 138.46M | 112.78M | 144.71M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 44.97M | 348.99M | 298.59M | 205.32M | 159.56M |
Total Liabilities | 30.45M | 39.13M | 26.8M | 29.17M | 14.86M |
Total Equity | -34.55M | 309.86M | 271.79M | 176.16M | 144.71M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -94.5M | -26.46M | -45.08M | -61.81M | -81.23M |
Investing | 49.44M | 45.13M | 69.56M | 55.01M | 110.86M |
Financing | 171k | N/A | 33k | 54k | 48.62M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -20.98M | -33.66M | -57.12M | -94.5M | -81.23M |
Investing | -3.59M | -146.32M | -10.44M | 49.44M | 110.86M |
Financing | -64k | 330.87M | 1.93M | 171k | 48.62M |
Market Cap | 347.75M |
Price to Earnings Ratio | -4.02 |
Price to Sales Ratio | 212.03 |
Price to Cash Ratio | 2.8 |
Price to Book Ratio | 2.43 |
Dividend Yield | - |
Shares Outstanding | 47.47M |
Average Volume (1 week) | 704.98k |
Average Volume (1 Month) | 387.78k |
52 Week Change | 178.52% |
52 Week High | 11.76 |
52 Week Low | 1.3301 |
Spread (Intraday) | 0.05 (0.68%) |
Company Name | Shattuck Labs Inc |
Address |
108 lakeland ave dover, delaware 19901 |
Website | https://www.shattucklabs.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions